Bone biopsy protocol for advanced prostate cancer in the era of precision medicine
Abstract
Metastatic biopsies are increasingly being performed in patients with advanced prostate cancer to search for actionable targets and/or to identify emerging resistance mechanisms. Due to a predominance of bone metastases and their sclerotic nature, obtaining sufficient tissue for clinical and genomic studies is challenging.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 19, 2017
- Source ID
- 10.1002/cncr.31173
Entities
People
- Adam D. Talenfeld
- Alexandros Sigaras
- Andrea Sboner
- Bradley B. Pua
- Brian D. Robinson
- Brian Sullivan
- Chantal Pauli
- David M. Nanus
- Himisha Beltran
- Joanna Cyrta
- Juan Miguel Mosquera
- Kenneth Wa Eng
- Kyungmouk Steve Lee
- Luis S. Beltran
- Marc H. Schiffman
- Mark A. Rubin
- Myriam Kossai
- Olivier Elemento
- Rema A. Rao
- Rohan Bareja
- Scott T Tagawa
- Shaham Beg
- Verena Sailer
Organizations
- Lower Manhattan Hospital
- National Institutes of Health
- New York University
- United States Department of Defense
- Weill Cornell Medicine